Differential regulation of rho GTPases during lung adenocarcinoma migration and invasion reveals a novel role of the tumor suppressor StarD13 in invadopodia regulation

[1]  Jing Sun,et al.  High expression of DLC family proteins predicts better prognosis and inhibits tumor progression in NSCLC , 2019, Molecular medicine reports.

[2]  M. El-Sibai,et al.  Cytotoxicity of [HuArgI (co)-PEG5000]-induced arginine deprivation to ovarian Cancer cells is autophagy dependent , 2019, Investigational New Drugs.

[3]  M. El-Sibai,et al.  RHOG Activates RAC1 through CDC42 Leading to Tube Formation in Vascular Endothelial Cells , 2019, Cells.

[4]  Yunjian Zhang,et al.  DLC2 operates as a tumor suppressor gene in breast cancer via the RhoGTPase pathway , 2018, Oncology letters.

[5]  H. Fahmi,et al.  Immunological modulation following bone marrow-derived mesenchymal stromal cells and Th17 lymphocyte co-cultures , 2018, Inflammation Research.

[6]  W. Muller,et al.  In vivo evidence supporting a metastasis suppressor role for Stard13 (Dlc2) in ErbB2 (Neu) oncogene induced mouse mammary tumors , 2018, Genes, Chromosomes and Cancer.

[7]  D. Atallah,et al.  Breast Density and Breast Cancer Incidence in the Lebanese Population: Results from a Retrospective Multicenter Study , 2017, BioMed research international.

[8]  F. Journé,et al.  Breast cancer cells and bone marrow mesenchymal stromal cells: a regulated modulation of the breast tumor in the context of immune response , 2017, Inflammation Research.

[9]  Wei Zhao,et al.  MicroRNA-125b promotes invasion and metastasis of gastric cancer by targeting STARD13 and NEU1 , 2016, Tumor Biology.

[10]  D. Lowy,et al.  DLC1 is the principal biologically-relevant down-regulated DLC family member in several cancers , 2016, Oncotarget.

[11]  Tao Xi,et al.  STARD13-correlated ceRNA network inhibits EMT and metastasis of breast cancer , 2016, Oncotarget.

[12]  J. Condeelis,et al.  Digging a little deeper: the stages of invadopodium formation and maturation. , 2014, European journal of cell biology.

[13]  Utku Horzum,et al.  Step-by-step quantitative analysis of focal adhesions , 2014, MethodsX.

[14]  L. Hodgson,et al.  A New Genetically Encoded Single-Chain Biosensor for Cdc42 Based on FRET, Useful for Live-Cell Imaging , 2014, PloS one.

[15]  M. El-Sibai,et al.  StarD13 is a tumor suppressor in breast cancer that regulates cell motility and invasion , 2014, International journal of oncology.

[16]  K. Hahn,et al.  The regulation of RhoA at focal adhesions by StarD13 is important for astrocytoma cell motility. , 2014, Experimental cell research.

[17]  M. El-Sibai,et al.  Effect of StarD13 on colorectal cancer proliferation, motility and invasion. , 2014, Oncology reports.

[18]  M. El-Sibai,et al.  Signaling networks of Rho GTPases in cell motility. , 2013, Cellular signalling.

[19]  W. Wu,et al.  Derepression of c‐Fos caused by MicroRNA‐139 down‐regulation contributes to the metastasis of human hepatocellular carcinoma , 2013, Cell biochemistry and function.

[20]  M. El-Sibai,et al.  The STAR of the DLC family , 2013, Journal of receptor and signal transduction research.

[21]  M. Guan,et al.  Downregulation of DLC-1 Gene by Promoter Methylation during Primary Colorectal Cancer Progression , 2012, BioMed research international.

[22]  Amanda Y. Chan,et al.  The small GTPase RhoG mediates glioblastoma cell invasion , 2012, Molecular Cancer.

[23]  M. El-Sibai,et al.  DLC2/StarD13 plays a role of a tumor suppressor in astrocytoma. , 2012, Oncology reports.

[24]  Tao Xi,et al.  MicroRNA-125b Induces Metastasis by Targeting STARD13 in MCF-7 and MDA-MB-231 Breast Cancer Cells , 2012, PloS one.

[25]  M. McNiven,et al.  Invasive matrix degradation at focal adhesions occurs via protease recruitment by a FAK–p130Cas complex , 2012, The Journal of cell biology.

[26]  S. Lo,et al.  Silencing of DLC1 Upregulates PAI-1 Expression and Reduces Migration in Normal Prostate Cells , 2011, Molecular Cancer Research.

[27]  E. Wilczek,et al.  Deleted in liver cancer protein family in human malignancies (Review). , 2011, Oncology letters.

[28]  Yi Zheng,et al.  Cdc42 in oncogenic transformation, invasion, and tumorigenesis. , 2011, Cellular signalling.

[29]  H. Schüler,et al.  Comparative Structural Analysis of Lipid Binding START Domains , 2011, PloS one.

[30]  J. Condeelis,et al.  A Novel Spatiotemporal RhoC Activation Pathway Locally Regulates Cofilin Activity at Invadopodia , 2011, Current Biology.

[31]  Chang-qing Yang,et al.  Role of RhoA in platelet-derived growth factor-BB-induced migration of rat hepatic stellate cells. , 2010, Chinese medical journal.

[32]  K. Hahn,et al.  Biosensors for Characterizing the Dynamics of Rho Family GTPases in Living Cells , 2010, Current protocols in cell biology.

[33]  H. Yagisawa,et al.  START-GAP2/DLC2 is localized in focal adhesions via its N-terminal region. , 2009, Biochemical and biophysical research communications.

[34]  H. Hirata,et al.  Focal adhesion‐localization of START‐GAP1/DLC1 is essential for cell motility and morphology , 2009, Genes to cells : devoted to molecular & cellular mechanisms.

[35]  J. Mosser,et al.  Integrative genome‐wide analysis reveals a robust genomic glioblastoma signature associated with copy number driving changes in gene expression , 2009, Genes, chromosomes & cancer.

[36]  Tsutomu Sasaki,et al.  IDENTIFICATION OF THE DELETED IN LIVER CANCER 1 GENE, DLC1, AS A CANDIDATE MENINGIOMA TUMOR SUPPRESSOR , 2008, Neurosurgery.

[37]  K. Hahn,et al.  RhoA/ROCK-mediated switching between Cdc42- and Rac1-dependent protrusion in MTLn3 carcinoma cells. , 2008, Experimental cell research.

[38]  D. Nie,et al.  Role of Rho GTPases in breast cancer. , 2008, Frontiers in bioscience : a journal and virtual library.

[39]  S. Lo,et al.  Deleted in liver cancer-1 (DLC-1): a tumor suppressor not just for liver. , 2008, The international journal of biochemistry & cell biology.

[40]  Douglas R Lowy,et al.  DLC-1:a Rho GTPase-activating protein and tumour suppressor , 2007, Journal of cellular and molecular medicine.

[41]  M. Berens,et al.  Molecular targets of glioma invasion , 2007, Cellular and Molecular Life Sciences.

[42]  Lewis H Romer,et al.  FAK potentiates Rac1 activation and localization to matrix adhesion sites: a role for betaPIX. , 2006, Molecular biology of the cell.

[43]  Y. Kloog,et al.  A Ras inhibitor tilts the balance between Rac and Rho and blocks phosphatidylinositol 3-kinase-dependent glioblastoma cell migration. , 2006, Cancer research.

[44]  N. Popescu,et al.  Expression profile of the tumor suppressor genes DLC-1 and DLC-2 in solid tumors. , 2006, International journal of oncology.

[45]  C. Waterman-Storer,et al.  Spatiotemporal Feedback between Actomyosin and Focal-Adhesion Systems Optimizes Rapid Cell Migration , 2006, Cell.

[46]  John Condeelis,et al.  Invadopodia and podosomes in tumor invasion. , 2006, European journal of cell biology.

[47]  K. Hahn,et al.  Spatiotemporal dynamics of RhoA activity in migrating cells , 2006, Nature.

[48]  I. Ng,et al.  Deleted in liver cancer 2 (DLC2) suppresses cell transformation by means of inhibition of RhoA activity. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[49]  Yukinori Endo,et al.  A Rac switch regulates random versus directionally persistent cell migration , 2005, The Journal of cell biology.

[50]  V. Tkach,et al.  The role of RhoA in the regulation of cell morphology and motility. , 2005, Cell motility and the cytoskeleton.

[51]  J. Segall,et al.  Molecular mechanisms of invadopodium formation , 2005, The Journal of cell biology.

[52]  J. Segall,et al.  Molecular mechanisms of invadopodium formation: the role of the N-WASP–Arp2/3 complex pathway and cofilin , 2005 .

[53]  Erik Sahai,et al.  Differing modes of tumour cell invasion have distinct requirements for Rho/ROCK signalling and extracellular proteolysis , 2003, Nature Cell Biology.

[54]  E. Sahai,et al.  ERK-MAPK signaling coordinately regulates activity of Rac1 and RhoA for tumor cell motility. , 2003, Cancer cell.

[55]  M. Westphal,et al.  Cost of migration: invasion of malignant gliomas and implications for treatment. , 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[56]  S. Goodman,et al.  Gene promoter hypermethylation in tumors and lymph nodes of stage I lung cancer patients. , 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.

[57]  I. Ng,et al.  Deleted in Liver Cancer (DLC) 2 Encodes a RhoGAP Protein with Growth Suppressor Function and Is Underexpressed in Hepatocellular Carcinoma* , 2003, The Journal of Biological Chemistry.

[58]  Yi Zheng,et al.  Rho GTPase-activating proteins in cell regulation. , 2003, Trends in cell biology.

[59]  Hilde van der Togt,et al.  Publisher's Note , 2003, J. Netw. Comput. Appl..

[60]  A. Hall,et al.  Rho GTPases in cell biology , 2002, Nature.

[61]  Irina Kaverina,et al.  Regulation of substrate adhesion dynamics during cell motility. , 2002, The international journal of biochemistry & cell biology.

[62]  E. Sahai,et al.  RHO–GTPases and cancer , 2002, Nature Reviews Cancer.

[63]  K. Guan,et al.  Function of the Rho Family GTPases in Ras-stimulated Raf Activation* , 2001, The Journal of Biological Chemistry.

[64]  A. Ridley.  Rho GTPases and cell migration. , 2001, Journal of cell science.

[65]  J. Segall,et al.  Lamellipodia in invasion. , 2001, Seminars in cancer biology.

[66]  A. Huttenlocher,et al.  Integrin-mediated adhesion regulates cell polarity and membrane protrusion through the Rho family of GTPases. , 2001, Molecular biology of the cell.

[67]  M. Schwartz,et al.  Focal adhesion kinase suppresses Rho activity to promote focal adhesion turnover. , 2000, Journal of cell science.

[68]  B. Zetter,et al.  Motility and invasion are differentially modulated by Rho family GTPases , 2000, Oncogene.

[69]  J. Segall,et al.  Chemoattractant‐induced lamellipod extension , 1998, Microscopy research and technique.

[70]  D. Morrison,et al.  The complexity of Raf-1 regulation. , 1997, Current opinion in cell biology.

[71]  Anne J. Ridley,et al.  The small GTP-binding protein rho regulates the assembly of focal adhesions and actin stress fibers in response to growth factors , 1992, Cell.

[72]  K. Kaibuchi,et al.  Small GTP-binding proteins. , 1992, International review of cytology.

[73]  Frank McCormick,et al.  The GTPase superfamily: a conserved switch for diverse cell functions , 1990, Nature.